Between 2007, when Mylan acquired the patent for the EpiPen, to 2015, the wholesale price had skyrocketed from $56.64 to $317.82 — a price increase of 461 percent. Similarly, compensation for Mylan CEO Heather Bresch increased astronomically over the same time period. According to NBC News, Bresch went from making $2.453,456 in 2007 to $18,931,068 in 2015, amounting to a 671 percent raise over eight years. (credit US Uncut).
This is clearly price-gouging for a LIFE SAVING DRUG that takes under $2 to produce & has SAVED countless lives.
We cannot allow this behavior resulting in parents trying to protect their children & anyone overall to choose between food or life.
Please address this issue to prevent this despicable practice.
We need it now!
This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.
